查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1782024

甲狀腺癌診斷市場（按產品、類型、技術、最終用戶、國家和地區）－2025 年至 2032 年全球產業分析、市場規模、市場佔有率及預測

Thyroid Cancer Diagnostics Market, By Product, By Type, By Technique, By End-User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 392 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告重點

2024 年甲狀腺癌診斷市場規模價值 31.6724 億美元，2025 年至 2032 年的複合年成長率為 5.5%。

甲狀腺癌診斷市場-市場動態

預計甲狀腺癌盛行率的上升將推動市場的成長。

隨著甲狀腺癌發生率的持續上升，對早期精準診斷方案的需求也顯著增加。這一發展趨勢促使人們更廣泛地採用先進的影像方法、分子診斷和微創活體組織切片技術，這些技術對於有效的疾病識別、分類和製定治療策略至關重要。美國每年約有53,000人被診斷出罹患甲狀腺癌。大多數甲狀腺癌患者的治療效果良好。然而，每年仍有約2,000人死於該疾病。此外，醫療保健支出和篩檢計劃的增加為市場帶來了成長機會。然而，先進診斷工具的高成本對市場擴張構成了挑戰。

甲狀腺癌診斷市場—關鍵見解

根據我們的研究分析師的分析，預計全球市場在預測期內（2025-2032 年）的年複合成長率約為 5.5%。

根據產品細分，預計儀器將在 2024 年佔據最大市場佔有率

根據類型細分，乳頭狀癌是 2024 年的主要類型

根據技術細分，成像技術是 2024 年的領先技術

根據最終用戶細分，醫院是 2024 年的領先技術

從地區來看，北美是 2024 年最大的收入來源

甲狀腺癌診斷市場-細分分析：

全球甲狀腺癌診斷市場根據產品、類型、技術、最終用戶和地區進行細分。

市場依產品細分為三類：儀器、試劑盒及耗材。儀器是市場成長的先驅。儀器是甲狀腺癌診斷市場成長的主要驅動力，因為它們在促進準確且有效率地檢測甲狀腺惡性腫瘤方面發揮著重要作用。這些設備包括先進的影像系統、分子診斷工具和活體組織切片設備，在臨床環境中的應用日益廣泛，以提高診斷準確性。它們能夠輔助早期診斷並追蹤病情進展，在甲狀腺癌的管理中發揮著至關重要的作用，從而推動了醫院、診斷中心和研究實驗室對它們的需求。

市場依類型分為兩類：乳頭狀癌、濾泡狀癌和其他。乳頭狀癌引領市場成長。它在甲狀腺癌診斷市場中佔有重要佔有率，佔確診病例的大多數，因為它在所有類型的甲狀腺癌中發病率很高。該亞型的發病率不斷上升，尤其是在女性和醫療體系發達的地區，這極大地刺激了對精準早期診斷解決方案的需求。這種領先地位凸顯了持續改進專門針對乳頭狀甲狀腺癌的診斷技術的必要性。

根據技術，市場可分為三個細分領域：血液檢測、影像學、活體組織切片和其他。影像學技術是市場成長的主要驅動力。影像學技術在甲狀腺結節和癌症的早期檢測、診斷和監測中發揮重要作用，極大地促進了甲狀腺癌診斷市場的擴張。超音波、電腦斷層掃描 (CT)、磁振造影 (MRI) 和正子斷層掃描 (PET) 等技術因其非侵入性特性以及提供詳細解剖和功能資訊的能力而被廣泛應用。在這些技術中，超音波是最常用的初步評估技術。

根據最終用戶，市場可分為三個部分：醫院、癌症診斷中心、學術和研究機構以及其他。醫院憑藉其廣泛的診斷基礎設施和尖端醫療技術，處於市場成長的前沿。作為癌症篩檢、診斷和治療的主要機構，醫院配備了影像系統、分子診斷工具和活體組織切片設備，這些對於精準檢測甲狀腺癌至關重要。患者數量的不斷增加、專業醫療保健專業人員的增加以及多學科護理方法的採用，進一步增強了醫院環境中對甲狀腺癌診斷的需求。此外，醫療支出的成長和醫院診斷能力的提升也促進了市場的擴張。

甲狀腺癌診斷市場—地理洞察

北美在市場成長方面處於領先地位，這主要得益於癌症診斷技術的進步。該地區擁有完善的醫療基礎設施、廣泛的先進成像系統以及對下一代定序 (NGS) 和 PCR 等分子診斷工具的廣泛採用。僅在美國，新診斷病例和死亡人數估計分別為 190 萬和 609,360 人。現有癌症診斷方法（包括正子斷層掃描 (PET)、X 光電腦斷層掃描 (CT) 和磁振造影 (MRS)）以及分子診斷技術的應用提高了早期發現率，不僅在癌症患者的治療管理中發揮著至關重要的作用，而且在癌症本身的早期識別中也發揮著至關重要的作用。在高認知度、強大的醫療保健系統和優惠政策的支持下，歐洲是市場成長第二大的地區。

甲狀腺癌診斷市場-競爭格局：

甲狀腺癌診斷市場競爭激烈，既有知名診斷領導者、專業生技公司，也有新興新創公司。各公司不斷創新，力求提高診斷精準度、縮短週轉時間並拓展地域覆蓋範圍。主要參與者正將資源投入新一代定序 (NGS)、人工智慧增強成像和分子診斷領域，以確保競爭優勢。一些知名公司也正進軍亞太、拉丁美洲和中東等新興市場，以利用甲狀腺癌發病率不斷上升以及醫療基礎設施投資不斷增加的優勢。

最新動態：

賽默飛世爾科技公司宣布，其體外診斷測試 Oncomine 已獲得美國食品藥物管理局 (FDA) 的批准，可用作 2 級 IDH 突變型膠質瘤的伴隨診斷。

2021 年 8 月 3 日——NorthStar Medical Radioisotopes, LLC 是用於醫學成像和治療目的的放射性藥物的創新、生產和商業化的全球領導者，該公司與 GE Healthcare 今天宣佈建立獨家協議，在美國製造和分銷碘-123 (I-123) 膠囊。

目錄

第1章：甲狀腺癌診斷市場概述

  • 研究範圍
  • 市場估計年限

第2章：執行摘要

  • 市場片段
    • 甲狀腺癌診斷市場產品片段
    • 甲狀腺癌診斷市場片段（按類型）
    • 甲狀腺癌診斷市場（按技術）
    • 甲狀腺癌診斷市場（按最終用戶）摘要
    • 甲狀腺癌診斷市場（按國家/地區）
    • 甲狀腺癌診斷市場（按地區）
  • 競爭洞察

第3章：甲狀腺癌診斷關鍵市場趨勢

  • 甲狀腺癌診斷市場促進因素
    • 市場促進因素的影響分析
  • 甲狀腺癌診斷市場限制
    • 市場限制的影響分析
  • 甲狀腺癌診斷市場機遇
  • 甲狀腺癌診斷市場未來趨勢

第4章：甲狀腺癌診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章：甲狀腺癌診斷市場：地緣政治緊張局勢升級的影響

  • COVID-19 疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：甲狀腺癌診斷市場模式

  • 2024年甲狀腺癌診斷市佔率分析
  • 按主要製造商分類的細分數據
    • 成熟玩家分析
    • 新興企業分析

第7章：甲狀腺癌診斷市場－依產品

  • 概述
    • 按產品細分的市佔率分析
    • 儀器
    • 套件和耗材

第 8 章：甲狀腺癌診斷市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 乳頭狀癌
    • 濾泡性癌
    • 其他

第9章：甲狀腺癌診斷市場—依技術

  • 概述
    • 按技術分類的細分市場佔有率分析
    • 驗血
    • 影像學
    • 活體組織切片
    • 其他

第 10 章：甲狀腺癌診斷市場 - 按最終用戶

  • 概述
    • 按最終用戶細分的佔有率分析
    • 醫院
    • 癌症診斷中心
    • 學術和研究機構
    • 其他

第 11 章：甲狀腺癌診斷市場 - 按地理分類

  • 介紹
    • 按地區分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美甲狀腺癌診斷主要製造商
    • 北美市場規模及預測（按國家/地區）
    • 北美市場規模及預測（按產品）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按技術）
    • 北美市場規模及預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲甲狀腺癌診斷主要製造商
    • 歐洲市場規模及預測（按國家/地區）
    • 歐洲市場規模及預測（按產品）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模與預測（按技術）
    • 歐洲市場規模及預測（按最終用戶）
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區甲狀腺癌診斷主要製造商
    • 亞太地區市場規模及預測（依國家）
    • 亞太地區市場規模及預測（依產品）
    • 亞太地區市場規模及預測（按類型）
    • 亞太地區市場規模及預測（依技術）
    • 亞太地區市場規模及預測（依最終用戶）
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲甲狀腺癌診斷主要製造商
    • 拉丁美洲市場規模及預測（按國家/地區）
    • 拉丁美洲市場規模及預測（按產品）
    • 拉丁美洲市場規模及預測（按類型）
    • 拉丁美洲市場規模及預測（按技術）
    • 拉丁美洲市場規模及預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲甲狀腺癌診斷主要製造商
    • MEA 市場規模及預測（依國家/地區）
    • MEA 市場規模及預測（依產品）
    • MEA 市場規模和預測（按類型）
    • MEA 市場規模及預測（依技術）
    • MEA 市場規模及預測（依最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 其餘地區

第 12 章：甲狀腺癌診斷產業主要供應商分析

  • 競爭儀錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd (Roche Diagnostics)
    • Siemens Healthineers
    • Thermo Fisher Scientific
    • GE HealthCare
    • Bio-Rad Laboratories
    • Agilent Technologies
    • Philips Healthcare
    • Illumina, Inc.
    • Daiichi Sankyo
    • Hologic, Inc.
    • Becton Dickinson
    • PerkinElmer, Inc.
    • Qiagen NV
    • Veracyte, Inc.
    • Exact Sciences
    • NeoGenomics
    • DiaSorin SpA
    • Guardant Health
    • Myriad Genetics
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV5448

REPORT HIGHLIGHT

Thyroid Cancer Diagnostics Market size was valued at US$ 3,167.24 Million in 2024, expanding at a CAGR of 5.5% from 2025 to 2032.

The diagnosis of thyroid cancer encompasses a thorough array of tests aimed at identifying and verifying the existence of cancer in the thyroid gland. This process includes physical assessments, blood analyses, imaging methods, biopsy techniques, and molecular or genetic evaluations. Timely and precise diagnosis is crucial for formulating effective treatment strategies and management, greatly enhancing patient outcomes and long-term survival rates. Sophisticated diagnostic instruments are vital in facilitating the prompt detection and categorization of thyroid tumors, allowing for personalized and targeted treatment options.

Thyroid Cancer Diagnostics Market- Market Dynamics

The increasing prevalence of thyroid cancer is anticipated to drive the growth of the market.

As the incidence of thyroid cancers continues to increase, there is a significant rise in the need for early and precise diagnostic solutions. This development is resulting in higher adoption of sophisticated imaging methods, molecular diagnostics, and minimally invasive biopsy techniques, all of which are crucial for effective disease identification, categorization, and treatment strategy formulation. Approximately 53,000 individuals in the United States are diagnosed with thyroid cancer annually. The treatment outcomes for the majority of thyroid cancers are quite favorable. Nevertheless, around 2,000 individuals succumb to the disease each year. Additionally, the rise in healthcare expenditures and screening initiatives presents a growth opportunity for the market. However, the high costs associated with advanced diagnostic tools pose a challenge to market expansion.

Thyroid Cancer Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2025-2032)

Based on Product segmentation, Instruments was predicted to show maximum market share in the year 2024

Based on Type segmentation, Papillary carcinoma was the leading Type in 2024

Based on Technique segmentation, the Imaging Technique was the leading Technique in 2024

Based on End-User segmentation, Hospitals were the leading Technique in 2024

Based on region, North America was the leading revenue generator in 2024

Thyroid Cancer Diagnostics Market- Segmentation Analysis:

The Global Thyroid Cancer Diagnostics Market is segmented based on Product, Type, Technique, End-User, and Region.

The market is segmented into three categories according to Product: Instruments, Kits, and consumables. Instruments are at the forefront of market growth. Instruments are the primary drivers of growth in the Thyroid Cancer Diagnostics market due to their essential function in facilitating accurate and efficient detection of thyroid malignancies. These devices, which encompass advanced imaging systems, molecular diagnostic tools, and biopsy equipment, are being increasingly utilized in clinical environments to improve diagnostic accuracy. Their capability to aid in early diagnosis and track disease progression has rendered them crucial in the management of thyroid cancer, thus propelling their demand in hospitals, diagnostic centers, and research laboratories.

The market is segmented into two categories according to Type: Papillary carcinoma, Follicular carcinoma, and others. Papillary carcinoma leads the growth of the market. It holds a significant share in the Thyroid Cancer Diagnostics market, representing the majority of diagnosed cases due to its high prevalence among all types of thyroid cancer. The increasing incidence of this subtype, especially among women and in areas with developed healthcare systems, has greatly fueled the demand for precise and early diagnostic solutions. This leadership underscores the necessity for ongoing improvements in diagnostic technologies specifically designed for papillary thyroid carcinoma.

The market is categorized into three segments based on Technique: Blood test, Imaging, Biopsy, and Other. The Imaging Technique is the primary driver of market growth. Imaging techniques significantly contribute to the expansion of the Thyroid Cancer Diagnostics market, propelled by their essential function in the early detection, diagnosis, and monitoring of thyroid nodules and cancers. Modalities such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) are extensively employed due to their non-invasive characteristics and their capacity to deliver detailed anatomical and functional information. Among these modalities, ultrasound is the most frequently utilized technique for initial assessment.

The market is categorized into three segments based on End-User: Hospitals, Cancer diagnostic centers, Academic and research institutes, and others. Hospitals are at the forefront of market growth due to their extensive diagnostic infrastructure and access to cutting-edge medical technologies. As the primary facilities for cancer screening, diagnosis, and treatment, hospitals are equipped with imaging systems, molecular diagnostic tools, and biopsy equipment that are crucial for the precise detection of thyroid cancer. The increasing influx of patients, the presence of specialized healthcare professionals, and the adoption of multidisciplinary care approaches further enhance the demand for thyroid cancer diagnostics within hospital environments. Moreover, the rise in healthcare spending and advancements in hospital-based diagnostic capabilities are also contributing to the expansion of the market.

Thyroid Cancer Diagnostics Market- Geographical Insights

North America leads in market growth, primarily due to advancements in cancer diagnostic technologies. The region has a well-established healthcare infrastructure, extensive access to advanced imaging systems, and a strong uptake of molecular diagnostic tools such as next-generation sequencing (NGS) and PCR. In the United States alone, the estimated figures for new diagnoses and deaths stand at 1.9 million and 609,360, respectively. The application of existing cancer diagnostic methods, including positron emission tomography (PET), X-ray computed tomography (CT), and magnetic resonance spectroscopy (MRS), along with molecular diagnostic techniques, has facilitated early detection rates and plays a crucial role not only in the therapeutic management of cancer patients but also in the early identification of cancer itself. Europe ranks as the second-largest region for market growth, supported by high awareness, strong healthcare systems, and favorable policies.

Thyroid Cancer Diagnostics Market- Competitive Landscape:

The market for thyroid cancer diagnostics is marked by fierce competition among well-established diagnostic leaders, specialized biotechnology companies, and new startups. Firms are persistently innovating to improve diagnostic precision, shorten turnaround times, and broaden their geographical reach. Major players are allocating resources toward next-generation sequencing (NGS), AI-enhanced imaging, and molecular diagnostics to secure a competitive advantage. Prominent companies are also venturing into emerging markets such as Asia-Pacific, Latin America, and the Middle East to take advantage of the growing incidence of thyroid cancer and the increased investment in healthcare infrastructure.

Recent Developments:

Thermo Fisher Scientific has announced that its in vitro diagnostic test, Oncomine, has been granted approval by the US Food and Drug Administration (FDA) for use as a companion diagnostic in grade 2 IDH-mutant glioma.

August 3, 2021 - NorthStar Medical Radioisotopes, LLC, a worldwide leader in the innovation, production, and commercialization of radiopharmaceuticals utilized for medical imaging and therapeutic purposes, along with GE Healthcare, has today declared the establishment of an exclusive agreement for the manufacturing and distribution of iodine-123 (I-123) capsules within the United States.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THYROID CANCER DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd (Roche Diagnostics)
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • GE HealthCare
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Philips Healthcare
  • Illumina, Inc.
  • Daiichi Sankyo
  • Hologic, Inc.
  • Becton Dickinson
  • PerkinElmer, Inc.
  • Qiagen N.V.
  • Veracyte, Inc.
  • Exact Sciences
  • NeoGenomics
  • DiaSorin S.p.A.
  • Guardant Health
  • Myriad Genetics
  • Others

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Instruments
  • Kits & consumables

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Papillary carcinoma
  • Follicular carcinoma
  • Other

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY TECHNIQUE- MARKET ANALYSIS, 2019 - 2032

  • Blood test
  • Imaging
  • Biopsy
  • Other

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Cancer diagnostic centers
  • Academic and research institutes
  • Other

GLOBAL THYROID CANCER DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Thyroid Cancer Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Thyroid Cancer Diagnostics Market Snippet by Product
    • 2.1.2. Thyroid Cancer Diagnostics Market Snippet by Type
    • 2.1.3. Thyroid Cancer Diagnostics Market Snippet by Technique
    • 2.1.4. Thyroid Cancer Diagnostics Market Snippet by End-User
    • 2.1.5. Thyroid Cancer Diagnostics Market Snippet by Country
    • 2.1.6. Thyroid Cancer Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Thyroid Cancer Diagnostics Key Market Trends

  • 3.1. Thyroid Cancer Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Thyroid Cancer Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Thyroid Cancer Diagnostics Market Opportunities
  • 3.4. Thyroid Cancer Diagnostics Market Future Trends

4. Thyroid Cancer Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Thyroid Cancer Diagnostics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Thyroid Cancer Diagnostics Market Landscape

  • 6.1. Thyroid Cancer Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Thyroid Cancer Diagnostics Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Instruments
    • 7.1.3. Kits & consumables

8. Thyroid Cancer Diagnostics Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 8.1.2. Papillary carcinoma
    • 8.1.3. Follicular carcinoma
    • 8.1.4. Other

9. Thyroid Cancer Diagnostics Market - By Technique

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Technique, 2024 & 2032 (%)
    • 9.1.2. Blood test
    • 9.1.3. Imaging
    • 9.1.4. Biopsy
    • 9.1.5. Other

10. Thyroid Cancer Diagnostics Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Cancer diagnostic centers
    • 10.1.4. Academic and research institutes
    • 10.1.5. Other

11. Thyroid Cancer Diagnostics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Thyroid Cancer Diagnostics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Thyroid Cancer Diagnostics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Thyroid Cancer Diagnostics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Thyroid Cancer Diagnostics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Thyroid Cancer Diagnostics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Technique, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Thyroid Cancer Diagnostics Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. F. Hoffmann-La Roche Ltd (Roche Diagnostics)
    • 12.2.3. Siemens Healthineers
    • 12.2.4. Thermo Fisher Scientific
    • 12.2.5. GE HealthCare
    • 12.2.6. Bio-Rad Laboratories
    • 12.2.7. Agilent Technologies
    • 12.2.8. Philips Healthcare
    • 12.2.9. Illumina, Inc.
    • 12.2.10. Daiichi Sankyo
    • 12.2.11. Hologic, Inc.
    • 12.2.12. Becton Dickinson
    • 12.2.13. PerkinElmer, Inc.
    • 12.2.14. Qiagen N.V.
    • 12.2.15. Veracyte, Inc.
    • 12.2.16. Exact Sciences
    • 12.2.17. NeoGenomics
    • 12.2.18. DiaSorin S.p.A.
    • 12.2.19. Guardant Health
    • 12.2.20. Myriad Genetics
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us